Proteomic snapshot of breast cancer cell cycle: G 1/ S transition point
Authors:
- 14 November 2012
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 13 (1) , 48-60
Abstract
The biological processes that unfold during the G 1‐phase of the cell cycle are dependent on extracellular mitogenic factors that signal the cell to enter a state of quiescence, or commit to a cell‐cycle round by passing the restriction point ( R ‐point) and enter the S ‐phase. Unlike normal cells, cancer cells evolved the ability to evade the R ‐point and continue through the cell cycle even in the presence of extensive DNA damage or absence of mitogenic signals. The purpose of this study was to perform a quantitative proteomic evaluation of the biological processes that are responsible for driving MCF ‐7 breast cancer cells into division even when molecular checkpoints such as the G 1/ S R ‐point are in place. Nuclear and cytoplasmic fractions of the G 1 and S cell‐cycle phases were analyzed by LC ‐ MS / MS to result in the confident identification of more than 2700 proteins. Statistical evaluation of the normalized data resulted in the selection of proteins that displayed twofold or more change in spectral counts in each cell state. Pathway mapping, functional annotation clustering, and protein interaction network analysis revealed that the top‐scoring clusters that could play a role in overriding the G 1/ S transition point included DNA damage response, chromatin remodeling, transcription/translation regulation, and signaling proteins.Keywords
Funding Information
- Virginia Tech and NCI (R21 CA126669-01A1)
This publication has 74 references indexed in Scilit:
- Med1 plays a critical role in the development of tamoxifen resistanceCarcinogenesis, 2012
- Tidying up loose ends: the role of polynucleotide kinase/phosphatase in DNA strand break repairTrends in Biochemical Sciences, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The DNA Damage Response: Making It Safe to Play with KnivesMolecular Cell, 2010
- When ribosomes go bad: diseases of ribosome biogenesisMolecular BioSystems, 2010
- GeneCards Version 3: the human gene integratorDatabase: The Journal of Biological Databases and Curation, 2010
- Crosstalk between c‐Myc and ribosome in ribosomal biogenesis and cancerJournal of Cellular Biochemistry, 2008
- PELP1—A novel estrogen receptor-interacting proteinMolecular and Cellular Endocrinology, 2008
- MicroRNA—implications for cancerVirchows Archiv, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005